Imperial College London

DrFrancesDavies

Faculty of MedicineDepartment of Infectious Disease

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 2065f.davies

 
 
//

Location

 

8N8Commonwealth BuildingHammersmith Campus

//

Summary

 

Summary

Summary

I am an Academic Clinical Microbiologist. In my daily practice, I see patients with infections that are becoming increasingly difficult to treat. My research focuses on developing new ways to tackle antimicrobial resistance (AMR): developing and using new methods to track the spread of resistance, utilising rapid diagnostic tools, optimising the care of patients with multi-drug resistant organisms, and translating the research findings back to patient care.

Publications

Journals

Ghani R, Mullish BH, Davies FJ, et al., 2022, How to adapt an intestinal microbiota transplantation program to reduce the risk of invasive multidrug-resistant infection, Clinical Microbiology and Infection, Vol:28, ISSN:1198-743X, Pages:502-512

Ghani R, Mullish BH, Roberts L, et al., 2022, The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases, Gut Microbes, Vol:14, ISSN:1949-0976, Pages:1-22

Rawson TM, Brzeska-Trafny I, Maxfield R, et al., 2022, A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi Metallo-beta-lactamase (NDM) producing Enterobacterales infection, Journal of Global Antimicrobial Resistance, ISSN:2213-7165

Boonyasiri A, Myall AC, Wan Y, et al., 2021, Integrated patient network and genomic plasmid analysis reveal a regional, multi-species outbreak of carbapenemase-producing Enterobacterales carrying both <i>bla</i><sub>IMP</sub> and <i>mcr-9</i> genes

Miglietta L, Moniri A, Pennisi I, et al., 2021, Coupling machine learning and high throughput multiplex digital PCR enables accurate detection of carbapenem-resistant genes in clinical isolates, Frontiers in Molecular Biosciences, Vol:8, ISSN:2296-889X, Pages:1-11

More Publications